Microsoft's Biological Implants

Microsoft's up to its old tricks of offering pretty baubles to the innocent with The Microsoft Biology Foundation:

The bioinformatics community has developed a strong tradition of open development, code sharing, and cross-platform support, and a number of language-specific bioinformatics toolkits are now available. These toolkits serve as valuable nucleation points for the community, promoting the sharing of code and establishing de facto standards.

The Microsoft Biology Foundation (MBF) is a language-neutral bioinformatics toolkit built as an extension to the Microsoft .NET Framework. Currently it implements a range of parsers for common bioinformatics file formats; a range of algorithms for manipulating DNA, RNA, and protein sequences; and a set of connectors to biological Web services such as NCBI BLAST. MBF is available under an open source license, and executables, source code, demo applications, and documentation are freely downloadable from the link below.

Gotta love the segue from "strong tradition of open development, code sharing and cross-platform support" to "here, take these patent-encumbered .NET Framework toys to play with".

The point being, of course, that once you have dutifully installed the .NET framework, with all the patents that Microsoft claims on it, and become locked into it through use and habit, you are part of the Microsoft-controlled ecosystem. And there you are likely to stay, since Microsoft doesn't even pretend any of this stuff will be ported to other platforms.

For, under the misleading heading "Cross-platform and interoperability" it says:

MBF works well on the Windows operating system and with a range of Microsoft technologies.

Yeah? And what about non-Microsoft operating systems and technologies?

We plan to work with the developer community to take advantage of the extensibility of MBF and support an increasing range of Microsoft and non-Microsoft tools as the project develops.

Well, that's a complete irrelevance to being cross-platform: it just says it'll work with other stuff - big deal.

If I were a biologist I'd be insulted at this thinly-disguised attempt to implant such patent-encumbered software into the bioinformatics community, which has a long and glorious tradition of supporting free software that is truly free and truly cross-platform, and thus to enclose one of the most flourishing and vibrant software commons.

Follow me @glynmoody on Twitter or identi.ca.

Interoperability: The New Battlefield

One word is starting to crop up again and again when it comes to Microsoft: interoperability - or rather the lack of it. It was all over the recent agreement with the EU, and it also lies at the heart of the OpenDocument Foundation's moves discussed below.

And now here we have some details of the next interoperability battles:

the EU Competition Commissioner’s office, with the first case decided by the EU Court of First Instance, now has started working intensively on the second case.

The new case involves three main aspects. First, Microsoft allegedly barred providers of other text document formats access to information that would them allow to make their products fully compatible with computers running on Microsoft’s operating systems. “You may have experienced that sometimes open office documents can be received by Microsoft users, sometimes not.”

Second, for email and collaboration software Microsoft also may have privileged their own products like Outlook with regard to interfacing with Microsoft’s Exchange servers. The third, and according to Vinje, most relevant to the Internet and work done at the IGF, was the problem of growing .NET-dependency for web applications. .NET is Microsoft’s platform for web applications software development. “It is a sort of an effort to ‘proprietise’ the Internet,” said Vinje.

That's a good summary of the problems, and suggests that the Commission is learning fast; let's hope that it doesn't get duped when it comes to remedies as it did the last time, apparently fooled by Microsoft's sleights of hand over patents and licences.